Medical and Chemical TOC Members

I, Emmanuel Addo-Yobo, residing in Ghana, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor in the Department of Child Health, Kwame Nkrumah University of Science and Technology (KNUST), School of Medicine and Dentistry (SMD), and Honorary Consultant Paediatrician with sub-specialty interest in paediatric pulmonology in the Directorate of Child Health, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. My responsibilities include general paediatric clinical care, clinical teaching and mentoring of undergraduate and postgraduate medical students. I am seconded by KNUST-SMD, to support clinical teaching of medical students in Child Health at the Asokwa Childrens’ Hospital, Kumasi, as its external clinical teaching site. Here, I am also in charge of clinical education as a member of the hospital board. I have been involved in many research activities on childhood asthma epidemiology in Ghana as Principal or Co-Investigator, some of which have been sponsored partly or fully by pharmaceutical companies. I do not receive any form of remuneration from any drug companies. I have, however, given educational lectures to medical personnel on childhood asthma in Ghana which were sponsored by drug companies in a purely academic capacity.
3. Yes
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: My business has an interest in the topics of the Montreal Protocol with regard to patients I attend to with asthma and COPD who may be using MDIs containing ODS where there are no other affordable and effective alternatives. My spouse is a business secretary working with a local financial institution in Ghana and has no interests in matters before the Protocol.
   • Government advice and other policy development: I served as a member of the National Expert Committee to review Standard Treatment Guidelines for Ghana (2016-2017). My role in this Committee included advising prescribers on safe and cost-effective treatments for asthma and COPD, and other disorders in my capacity as a clinician. I have been involved in discussions on asthma treatment guidelines for the Ghana Thoracic Society (2023). I am also the current chair of the National Poliomyelitis Expert Committee (NPEC) as part of Ghana’s poliomyelitis eradidation activities.
   • Paid research activities, fellowships or grants: I am currently the country Principal Investigator for a multi -African country asthma study - “Achieving Control of Asthma in Children in Africa (ACACIA) Study” - and a sub-study on air pollution and asthma – “Children’s Air Pollution Profiles in Africa (CAPPA) Study”, aspects of which involve information on use of asthma medications in children.
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is the Ozone Secretariat of the United Nations Environmental Programme (UNEP).
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. Yes
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Emmanuel Addo-Yobo 
Date: 2023-12-2

I, Fatima Alshatti, residing in Kuwait, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a consultant to the International Ozone Committee of Kuwait Public Authority of Environment, having previously worked in the Petroleum Private Sector. My responsibilities are to ensure that information from Kuwait is provided and to help the gulf to understand and comply with Montreal Protocol.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have an interest in the work of the MCTOC and the outcomes of the Montreal Protocol because of my consulting role with KEPA
   • Government advice and other policy development: Yes in my role I provide consulting advice to the Kuwait Government about the Montreal Protocol, including about compliance requirements.
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is, UNEPs Ozone Secretriat.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Fatima Alshatti

Date: 2023-12-06 

I, Paul Atkins, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a retired Pharmaceutical Executive who has worked on the Development and Commercialization of inhaled products (MDIs, DPIs and Nebulizers) for over 35 years. I currently serve as Executive Chairman of Nob Hill Therapeutics, a pre-clinical company that is developing a novel dry powder nebulizer. I consult for several pharmaceutical companies through my company Inhaled Delivery Solutions LLC.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   1. Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   2. Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My wife and I have ownership of shares in several of our current or former companies including Novartis and AstraZeneca, both of which have products in the inhaler space
   3. Employment, consultancy, directorship or other positions: As described above. No additional directorship positions
   4. Government advice and other policy development: None  
   5. Paid research activities, fellowships or grants: None
   6. Other interests: None
5. The source of funding for my participation in the work of TEAP is personal funding
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Paul Atkins
Date: 2024-01-13
 

I, William Auriemma, residing in United States of America, a Member of Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Chairman / CEO of Diversified CPC International, a leading supplier of aerosol propellants, foam expansion gasses, and natural refrigerants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following  
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. supplier of aerosol propellants
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. Shareholder Diversified CPC International
   • Employment, consultancy, directorship or other positions: Diversified CPC, Chairman Emeritus Household & Commercial Products Association.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. Diversified CPC provides funding for my participation
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: william n auriemma 
Date: 2024-02-12

I, Christian SEKOMO BIRAME, residing in Rwanda, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am the Director General of the National Industrial Research and Development Agency (NIRDA) and part time Lecturer at the University of Rwanda (UR) in the College of Science and Technology (CST) / School of Science (SoS) / Department of Chemistry. I used to teach the following modules: Analytical Chemistry I & II; Environmental Chemistry I, Fundamental of waste management at undergraduate level and Water Quality Principles and Management; Wastewater Treatment and Disposal; Supervision of laboratory work and BSc final year project as well as MSC and PhD thesis. Beside my daily university workload, I used to conduct many consultancies services for the Ministry of Environment and REMA mainly related with waste management in general (water quality analysis; Hazardous chemical waste management (POPs, PCBs and Hg). Recently I have worked with a team of IT specialists in the development of an IT system for ODS management in Rwanda for REMA.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have an interest to conduct consultancy services in the topics of the Montreal Protocol because my potential client is also interested in these topics. I consult for an organisation that supports the Montreal Protocol in phasing out controlled substances.
   • Government advice and other policy development: See above comment
   • Paid research activities, fellowships or grants: None  
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is provided by the Ozone Secretariat to support travel and accommodation when I will be attending MCTOC planned meetings.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Christian SEKOMO BIRAME 
Date: 2024-01-04 

I, Stephanie Bogle, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an environmental protection specialist with the US Environmental Protection Agency in the Greenhouse Gas Reporting Branch of the Climate Change Division. I have expertise in fluorinated greenhouse gas consumption and emissions from the electronics manufacturing, aluminum production, magnesium production and electrical transmission and distribution systems. I lead the development of the emissions estimates for these sectors for the Inventory of US Greenhouse Gas Emissions and Sinks. I also lead the verification of annual greenhouse gas reports and regulatory revisions for the electronics manufacturing and the petroleum and natural gas systems subparts for the EPA Greenhouse Gas Reporting Program.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I work for the US Environmental Protection Agency in the Climate Change Division. I provide technical review and advice on regulations and reporting related to fluorinated greenhouse gas consumption and emissions by the electronics manufacturing, aluminum production, magnesium production and electrical transmission and distribution sectors.
   • Government advice and other policy development: Yes, I work at the US Environmental Protection Agency. See above.
   • Paid research activities, fellowships or grants: No.
   • Other interests: No.
5. The source of funding for my participation in the work of TEAP is the USEPA
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Stephanie Bogle 
Date: 2023-12-28 

I, Steve Burns, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Global Product Leader at Astrazeneca. I lead the development of new medicines for respiratory and inflammatory diseases. I Support MCTOC by providing knowledge about the treatment of respiratory diseases and the technical opportunities and challenges associated with changing inhalers to more environmentally friendly options.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service. I understand
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I have shares and share options in AstraZeneca which currently develops and manufactires inhaled products for respiratory treatments (including pMDIs)
   • Employment, consultancy, directorship or other positions: AstraZeneca
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests:
5. The source of funding for my participation in the work of TEAP is AstraZeneca
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Steve Burns
Date: 2023-12-20 

I, Nick Campbell, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am retired since 1 August 2023.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   •  Employment, consultancy, directorship or other positions: None  
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: IETA Fellow  
   • Other interests: None
5. At present, I have no source of funding for my participation in the work of TEAP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Nick Campbell 
Date: 2023-12-26 

I, Andrea Casazza, residing in Italy, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am responsible for the technical product development of pharmaceutical products for Chiesi Farmaceutici. My organization is in charge to follow chemical, formulation and device development of inhalation, injectable and oral products. The development of inhalation products is of particular interest and this includes the use of propellants for the development of pressurised metered dose inhalers (pMDIs).
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: As an employer of Chiesi Farmaceutici, I have interest in the topic of Montreal Proptocol because we are manufacturing pMDI products containing HFC and Dry Powder for inhalation (DPI); we are committed to develop alternative low global warming potential pMDIs.
   • Government advice and other policy development: No  
   • Paid research activities, fellowships or grants: No
   • Other interests: NO
5. The source of funding for my participation in the work of TEAP is Chiesi Farmaceutici
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Andrea Casazza 
Date: 2024-02-28 
 

I, Richard Cooke, residing in Canada, a Member of the Medical and Chemicals Technical Options Committee, and Member of TEAP task force on decision XXXV/11 (Life-cycle refrigerant management) declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a principal in a Canadian consulting company (Man-West Environmental Group Ltd. engaged in international assignments with IFIs, UN Agencies, and private sector clients on the project management and technical support assignments related to waste management (hazardous, municipal, chemical), cotaminated sites, circular economy, institutional technical assistance, chemicals related convention implementation (Stockholm, Basel, Montreal Protocol). Specifically relevant to TEAP related activities, this includes preparation and implementation of GEF and MLF projects involving KIPs, end of Life controlled substance management, assessment of halogenated chemicals technologies, and general country level compliance with Montreal Protocol obligations. Primary personal volunter interest include environmnetal and natural spaces protection in the Canadian Rockies and northern Canada undertaken through membership in and working with local ENGOs and boad memberships including the Oldman Watershed Council in Southern Alberta.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My consultancy work may involve undertaking benfical commercial contractal arrangements to implement activities that may be funded by the MLF.
   • Employment, consultancy, directorship or other positions: Man-West Environmental Group Ltd, - President (See Section 2 above). Director - Oldman Watershed Council
   • Government advice and other policy development: 
   • Paid research activities, fellowships or grants: Assisting in completion of a report making the economic and environmental case for destruction of ODSs and HFCs in local cement kilns being prepared by an NGO (International Governance and Sustainability Institute).
   • Other interests: See Section 2 above related to ENGO volunteer activities
5. The source of funding for my participation in the work of TEAP is my company/employer and personal resources, all o which is considered a voluntary pro-bono, non-tax deductable contribution to the work of the montreal Protcol.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Richard Cooke 
Date: 2024-02-01

I, Takeshi Eriguchi, residing in Japan, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a manager at AGC Inc. based on Tokyo, which manufactures HCFCs, HFCs, HFEs, HCFOs and HFOs. I'm working for the company to support its advocacy activities.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I own shares of stock in my employer, AGC Inc., which is an entity with an interest in the Montreal Protocol as stated above. Should a conflict arise due to activities related to my employer, I will recuse myself as delineated in Decision XXIV/8.
   • Employment, consultancy, directorship or other positions: I'm working for AGC Inc. for its advocacy activities.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is from AGC Inc.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Name: Takeshi Eriguchi
Date: 2023-03-28

I, JIN FANG , residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am professor of Institute of respiratory diseases, Guangzhou Medical University. My responsibilities include research and development of inhalation preparation.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. I am one of the inventors of two MDI inhalant related patents. In China, the patent inventor does not have the patent rights and interests. Although the patents have been authorized for many years, I have not obtained any economic benefits.
   • Details of authorized patents are as follows:
     1. The invention relates to an inhalation pressure quantitative aerosol pharmaceutical composition and a preparation method thereof, Jin Fang; Wen Cong; Li Lixin, 2021-4-27
     2. A quantitative inhalation aerosol of benzcycloquinium bromide and its preparation method, Jin Fang; Zhao Shuqiang; Zhang Liu; Deng Wanding; Ding Hao; Wen Shouming;Zhao, 2012-2-22
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am currently a member of the Chinese Pharmacopoeia Committee, participating in the formulation of Chinese Pharmacopoeia related to inhaled preparations; the chairman of the Pharmaceutical Engineering Committee and participates in the conference organization of pharmaceutical industry including inhaled preparations. Both the above special committees are non-profit organizations. And as PI in Institute of respiratory diseases, Guangzhou Medical University, engaged in inhalation related scientific research work.
   • Government advice and other policy development: I drafted China's National Strategy for CFCs Elimination in MDIs and the Action Plan for Replacing Halon in Chinese Metered Dose Inhaler.
   • Paid research activities, fellowships or grants: I have been funded by the National Pharmacopoeia Committee to study the general principles of inhalation preparations, and funded by the Ministry of science and technology of the People’s Republic of China to carry out the research on the pharmaceutical compositions and preparation methods of benzocycloquinium bromide inhalation aerosol, salbutamol sulfate aerosol and inhalation pressure quantitative aerosol.
   • Other interests:
5. Self-funding or by MCTOC (funding for travel to meetings will be provided by UNEP's Ozone Secretariat)
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: JIN FANG
Date: 2024-01-15
 

I, Maureen George, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Professor at Columbia University School of Nursing. My responsibilities include serving as the principal investigator of an independent program of research in chronic respiratory diseases in vulnerable populations. I also am an Assistant Dean, Research & Scholarship and the PhD Program Director. I teach in the PhD program, and serve on other committees to meet university service requirements.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Honoraria received for advisory/consultant roles with Astra-Zeneca, Genentech, Insmed, Sanofi/Regeneron and Teva Pharmaceuticals. I am a speaker for Astra-Zeneca and Sanofi/Regeneron.
   • Government advice and other policy development: I serve on an NIH study seciton revieiwng grants.
   • Paid research activities, fellowships or grants: Grants from the NIH only  
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is my employer, Columbia University School of Nursing, for in-kind contributions to her committee participation and travel to MCTOC meetings.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Maureen George 
Date: 2023-12-29

I, Jianxin Hu, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Professor of Environmental Sciences at Peking University in China. My responsibilities include teaching and researching environmental management on Chemicals, especially related to HFCs, ozone-depleting substances, and persistent organically pollutants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   •  Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   •  Employment, consultancy, directorship or other positions:
   •  Government advice and other policy development:
   •  Paid research activities, fellowships or grants:
   • Other interests:
5. The source of funding for my participation in the work of TEAP is UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Jianxin Hu
Date: 2023-12-26

I, Ryan Hulse, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Sr. Research and Development Director at Honeywell International. My responsibilities include leading the applications and process development teams in the development of new products in the areas Aerosol (including MDI propellants), Solvent, Refrigerants and Foam Blowing Agents.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. As part of my work at Honeywell I have developed aerosol, solvent, refrigeratn and blowing agent alternatives to CFC and HCFCs. These rights for the patents are wholly owned by Honeywell.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Employeed by Honeywell  
   • Government advice and other policy development: none
   • Paid research activities, fellowships or grants: none  
   • Other interests:
5. The source of funding for my participation in the work of TEAP is from Honeywell
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Ryan Hulse
Date: 2023-12-27 

I, PROF JAVAID KHAN , residing in Pakistan, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a pulmonologist working at a private medical university in Karachi, Pakistan. My interests include taking care of patients with asthma and COPD. I also create awareness in the public and in the medical field on the importance of the environment. I work to ensure that low cost MDI and DPI are available for our patients.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Professor of Medicine at the Aga Khan University
   • Government advice and other policy development: NONE
   • Paid research activities, fellowships or grants: As professor in an academic institution I also do research which is funded by various funding agencies. My area of interest is tobacco control. I do not receive any money from a tobacco company. Funding for tobacco control received from campaign for tobacco free kids, NIHR UK, University of York UK
   • Other interests:
5. The source of funding for my participation in the work of TEAP is BY UNDP
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. NO
8. NO
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: PROF JAVAID KHAN 
Date: 2024-01-15
 

I, Andy Lindley, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant providing services to Koura Global and EFCTC. My responsibilities include the European Fluorocarbon Technical Committee (EFCTC) mainly focused on HFCs and HFOs, their applications and EFCTC website content development and newsletter production.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am an independent consultant providing services to Koura Global and the European Fluorocarbon Technical Committee (EFCTC)
   • Government advice and other policy development: No  
   • Paid research activities, fellowships or grants: No
   • Other interests:
5. The source of funding for my participation in the work of TEAP is none as no funding is required for my participation as a corresponding member
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Andy Lindley
Date: 2023-12-27

I, Dr. Banda Narsaiah, residing in India, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am basically a synthetic organic chemist developed technologies for ozone friendly chemicals such as Hydrofluorocarbons, guided 21 students for their Ph. D program on synthesis of novel fluoroorganic molecules of biological interest and retired as Chief Scientist & Head, Fluoroorganic division, Indian Institute of Chemical Technology, Hyderabad 500007, India.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
5. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. No
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. No
   • Employment, consultancy, directorship or other positions: No
   • Government advice and other policy development: Yes. As a member in empowered steering committee of ozone cell, I will participate in meetings on implementation of Montreal Protocol to phase-out HCFCs and will screen, recommend promising projects submitted to ozone cell for financial assistance through Multilateral Fund. As a member in Telangana State Environmental Impact Assessment Authority will give environmental clearance to various projects include establishment and expansion of chemical industries, mining projects, construction of buildings of built up area more than 20,000 square metres and so on.
   • Paid research activities, fellowships or grants: Paid research activities, fellowships or grants: No
   • Other interests: No
6. The source of funding for my participation in the work of TEAP is United Nations Environment Program (UNEP).
7. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
8. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
9. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
10. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Name:Dr. Banda Narsaiah
Date: 2023-03-28

I, RABINDER NATH KAUL, residing in India, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a consultant and presently Secretary of REGMA, in industry associaion of fluorocarbon refrigerant gasses manufactrers in India. I also take up consulting work for SRF company as a consultant. My responsibilities include work related to Montreal Protocol and related MEAs and the regulatory issues.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: SAME AS ABOVE
   • Government advice and other policy development: Do not provide advice on significant issues to a Government in respect of policy.
   • Paid research activities, fellowships or grants: I do not receive paid research activities or any fellowships /grants relevant to the TEAP activity.
   • Other interests:
5. The source of funding for my participation in the work of TEAP is provided by Ozone Secretariat for travel and stay for MCTOC meetings as Article 5 member participant .
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: RABINDER NATH KAUL 
Date: 2023-12-28

I, Timothy James Noakes, residing in United Kingdom, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a technical expert on the manufacture and use of inhalation aerosol propellants. I am employed by Koura, the world's leading supplier of medical propellants.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I receive shares as part of a corporate compensation package.
   • Employment, consultancy, directorship or other positions: I am employed by Koura, a global company manufacturing HFCs and their replacements. I work as a technical specialist with medical propellant HFCs.
   • Government advice and other policy development: none  
   • Paid research activities, fellowships or grants: none
   • Other interests: none
5. The source of funding for my participation in the work of TEAP is from my employer
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Timothy James Noakes 
Date: 2024-01-08

I, John G. Owens, residing in United States of America, a Consulting Expert of the Fire Suppression Technical Options Committee, and Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an independent consultant providing technical advice to clients on organofluorine compounds. One client, Standard Fluids Corporation, supplies alternatives to halon and other ODSs. I was formerly employed by the 3M Company which has been a manufacturer of alternatives to ODSs. 3M has announced it will discontinue production of those products by the end of 2025.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I own shares of stock in my former employer, 3M Company, which is an entity with an interest in the Montreal Protocol as a producer of alternative substances. Should a conflict arise due to activities related to a client or my former employer, I will recuse myself as delineated in Decision XXIV/8.
   • Employment, consultancy, directorship or other positions: I am an independent consultant to a variety of clients, one of which may be impacted by decisions taken under the Montreal Protocol. Standard Fluids Corporation supplies alternatives to halon and other ODSs.
   • Government advice and other policy development: I do not provide advice to a government or for other policy development.
   • Paid research activities, fellowships or grants: I am not a recipient of any paid research activities, fellowships or grants.
   • Other interests: I have no other interests related to the subject matter of the Technology and Economic Assessment Panel or the Montreal Protocol.
5. The source of funding for my participation in the work of TEAP is one of the clients for whom I consult. The Standard Fluids Corporation is an international chemical supplier based in the United States. Some of the products supplied by Standard Fluids Corporation are alternatives to halons and other ODSs.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: John G. Owens
Date: 2024-01-10

I, Jose Pons, residing in United States of America, a Member of the Medical and Chemicals Technical Options Committee till 31st December 2022 declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an aerosol filler and have been involved with the Montreal Protocol since 1989
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • I do not have Employment, consultancy, directorship or other positions with an interest in the subject matter.
   • I do not have a rol in government advice or other policy development
   • I do not do paid research activities, fellowships or grants
   • Other interests, I want to contribute to the protection of the Ozone layer and the climate system. (5) I pay for my time. UNEP has paid my travel in the past.
5. I pay for my time. UNEP has paid my travel in the past.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2022 after I have signed it.

Name:José Ignacio Pons
Date: 2023-03-21

I, John Pritchard, residing in United Kingdom of Great Britain and Northern Ireland, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am acting as an independent consultant to clients developing respiratory drugs, delivery systems and digital healthcare, trading under the company name of Inspiring Strategies
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My wife and I have minority ownership of shares in various pharmaceutical companies who develop, manufacture and sell respiratory products that are impacted by decisions taken under the Montreal Protocol.
   • Employment, consultancy, directorship or other positions: I am a non-Executive Director for Cardiff Scintigraphics, a contract research organisations providing formulation development and testing of inhaled products. In addition, I am Chairman of Acu-flow, a company developing novel nebuliser technology and sit on 3 scientific advisory Boards for companies involved in the development of respiratory therapies. Beyond this, I consult to a variety of clients, some of whom may be commercially impacted by decisions taken under the Montreal Protocol.
   • Government advice and other policy development: None  
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. I currently have received no funding for my participation in the work of TEAP. Travel expenses might in the future be supported either by client relationships or the UK Government.
6. Pursuant to paragraph 11 of the COI Guidelines, I have declined to disclose confidential information falling within paragraph 10 of those Guidelines, namely the identity of my clients. I currently have no client contracts that would represent a conflict of interest. However, should I be engaged by sucha client in the future, I will recuse myself from any decisions that would materially affect them.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: John Pritchard 
Date: 2024-02-28 
 

I, Rabbur Reza, residing in Bangladesh, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I work as full time Chief Operating Officer at Beximco Pharmaceuticals Ltd, Bangladesh, as Managing Director at Nuvista Pharma Ltd., Bangladesh and as Chief Executive Officer of Synovia Pharma PLC, Bangladesh. As the operational leader, I am overseeing these Company’s business operations, which include pharmaceutical formulation and raw material manufacturing & quality control, research & development, regulatory affairs, training (learning & development management), sales, marketing and brand management, distribution, international business development, informational technology, medical affairs, project management, human resources etc.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. My employer Beximco Pharmaceuticals is the largest medical inhalers (MDI & DPI) manufacturer in Bangladesh and has an interest in the topics of Montreal Protocol, as it is engaged in development, manufacturing and marketing of MDIs in local and international markets. I have no proprietary interest in alternatives or substitutes to ODS.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I work as full time Chief Operating Officer at Beximco Pharmaceuticals Ltd, Bangladesh, as Managing Director at Nuvista Pharma Ltd., Bangladesh and as Chief Executive Officer of Synovia Pharma PLC, Bangladesh. I also serve as a director on the board of BioCare Manufacturing Sdn Bhd., Malaysia. BioCare is involved in manufacturing MDIs. My spouse is a medical practitioner and has no interest in matters before the Protocol.
   • Government advice and other policy development: None.
   • Paid research activities, fellowships or grants: None.
   • Other interests: None.
5. The source of funding for my participation in the work of TEAP is UNEP’s Ozone Secretariat, which funds my travel expenses for participation on MCTOC.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2023 after I have signed it.

Signed:Rabbur Reza
Date: 2023-03-28

I, David Sherry, residing in United Kingdom, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Co-Director and co-owner of Nolan Sherry and Associates Ltd (NSA). NSA specialises in the chlorine and fluorine chemical industries, providing technical, commercial, strategic and regulatory advice to the chemical industry, trade associations and government organisations. My responsibilities have included studies on HFOs and CTC, chloromethanes, chloroethanes, the commercial outlook for CTC; technical expertise in patent law, due diligence audits of CDM beneficiaries, provision of estimated emission rates for various chlorocarbons to various atmospheric researchers, and various evaluation and monitoring projects for UNMFS, UNDP, and World Bank.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. My interests, and those of my personal partner and dependents include the following
   • Financial interests: I have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. I have ownership and shares or bonds in an entity with an interest in the subject matter of the meeting or work. (co-owner of NSA Ltd as described above)
   • Employment, consultancy, directorship or other positions: As above  Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None  
   • Other interests: None
5. As a self-employed consultant, the time, medical requirements for travel, and cost of my contribution to MCTOC is self-funded. The source of funding for my on-location participation in the work of the MCTOC 2019-2023 has been UK Department of Environment, Food, and Rural Affairs (DEFRA), which funded specific travel and hotel costs with limited DSA.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: David Sherry 
Date: 2024-01-31 
 

I, Peter Sleigh, residing in United Kingdom, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I retired from working as the Regulatory manager for Koura at the end of 2022 and I am now acting as an independent consultant providing occasional services to Koura. Koura has an interest in the topics of the Montreal Protocol because they sell fluorochemicals controlled by the protocol.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Independant consultant to Koura  
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None  
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is currently self funding for 2024 as funding demands are expected to be limited.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Peter Sleigh
Date: 2024-01-11 

I, Jørgen Vestbo, residing in Denmark, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Respiratory Physician and I see respiratory outpatients in an outpatient clinic in Copenhagen, Denmark. I am also Professor emeritus of Respiratory Medicine at the University of Manchester, Manchester, UK. Besides clinical work, my responsibilities include clinical research where my area of focus is on chronic obstructive pulmonary disease (COPD) and inhaled therapies.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests:
   • Financial interests:
   • Employment, consultancy, directorship or other positions: I have received honoraria from pharmaceutical companies (ALK-Abello, AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK, Novartis and Teva) for advising and presenting. All work is being invoiced through a Danish tax registered one-man company, Vestbo medical, VAT Reg No 21215430.
   • Government advice and other policy development: None  
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is personal.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Jørgen Vestbo 
Date: 2024-01-15 
 

I, Kristine Whorlow AM, residing in Australia, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am the inaugural, now retired, CEO of the National Asthma Council Australia. My responsibilities included producing the national treatment guidelines for asthma and implementing these through an extensive national program of primary care health professional education as well as conducting national promotional campaigns on asthma for consumers. I was also responsible for conducting outreach education activities in Asia Pacific. I am currently the Vice President of the Global Allergy and Airways Patient Platform (GAAPP), the only global patient organisation in this field whose main role is to support existing and emerging patient organisations dedicated to patient support and advocacy in airways disease and allergy.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am a member of an AstraZeneca advisory panel which discusses asthma programs around the world.
   • Government advice and other policy development: Participation in the stakeholder meetings(including government) in Australia being held to discuss the implications and necessary policies and actions to be taken to educate health professionals and patients about the forthcoming introduction of low carbon footprint inhalers.
   • Paid research activities, fellowships or grants: None
   • Other interests: None relevant
5. The source of funding for my participation in the work of TEAP is myself.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Kristine Whorlow AM 
Date: 2024-02-01
 

I, Alexander Wilkinson, residing in United Kingdom, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Consultant Respiratory Physician with the East and North Hertfordshire NHS Trust.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I publish research papers and give lectures on the environmental sustainability of healthcare and respiratory treatments. Some of these are supported by pharmaceutical companies.
   • Government advice and other policy development: I am a member of NHS England inhaler experts working group.
   • Paid research activities, fellowships or grants: Nil  
   • Other interests:
5. The source of funding for my participation in the work of TEAP is East and North Hertfordshire NHS Trust, which allows me to take leave and provides travel support to attend meetings. I work voluntarily as Member of MCTOC.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Alexander Wilkinson 
Date: 2024-01-10

I, Gerallt Williams, residing in France, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a Director at Aptar Pharma, a drug delivery device company.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am a Director at Aptar Pharma, a drug delivery device company.
   • Government advice and other policy development: I have no involvement with government advice or policy development.
   • Paid research activities, fellowships or grants: I have no paid research activities, fellowships or grants.
   • Other interests: None
5. The source of funding for my participation in the work of TEAP is via my employer Aptar Pharma
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Gerallt Williams 
Date: 2024-01-08 

I, Ashley Woodcock, residing in United Kingdom, a Co-chair of the Technology and Economic Assessment Panel (TEAP), Member of the Medical and Chemicals Technical Options Committee, and Member of TEAP task force on decision XXXV/11 (Life-cycle refrigerant management) declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor of Respiratory Medicine at University of Manchester UK and a Consultant Physician at the Manchester University NHS Foundation Trust
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body. I am Chairman of Axalbion (Cough Treatment) and Reacta Healthcare (Allergy Diagnosis), neither of which have any proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • I am Chairman of the Medicines Evaluation Unit (MEU), which carries out Phase 1-4 clinical trials in patients with respiratory disease, including novel inhaled therapies. It is owned by the NW Lung Centre Charity, which puts all surplus into its charitable aims to improve the life of pateints with lung disease through research and improved care.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I have acted as a consultant for GlaxoSmithKline and Orion. I have presented on green inhalers at a symposium for Orion
   • Government advice and other policy development: None relevant  Paid research activities, fellowships or grants: None relevant
   • Other interests: None relevant
5. My TEAP Co-chair role is voluntary. The source of funding for my travel/accomodation to participate in the work of TEAP is my University and Hospital, and the United Kingdom Government (DEFRA).
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Ashley Woodcock 
Date: 2023-12-27 
 

I, Nee Sun Choong Kwet Yive, residing in Mauritius, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a lecturer at the University of Mauritius where I teach Analytical and Physical Chemistry at the Undergraduate and Postgraduate levels. I also carry out research focusing on pollution by heavy metals and organic pollutants such as Persistent Organic Pollutants
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions:
   • Government advice and other policy development:
   • Paid research activities, fellowships or grants:
   •  Other interests:
5. The source of funding for my participation in the work of TEAP is UNEP Ozone Layer Secretariat
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Nee Sun Choong Kwet Yive 
Date: 2023-12-29

I, Arzu Yorgancıoğlu, residing in Turkey, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a professor in Respiratory Medicine at Celal Bayar University, Medical Faculty, Department of Pulmonology. My main area is obstructive lung diseases and inhaler therapy. I see patients both in out and inpatient clinics . I also teach and make research(describe your activity) I am the Chair of GINA Board of Directors
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   •  Employment, consultancy, directorship or other positions: I received honoraria from pharmaceutical companies for advisory boards and presenting (Astra Zeneca,GSK,Novartis,Abdiİbrahim,Bilim ,DEVA, Chiesi
   • Government advice and other policy development: I have been the Chair of WHO GARD and worked as advisor to WHO and Turkish MoH . I have served as Chair of ERS Advocacy and currently serve as chair of GINA Board of directors.
   • Paid research activities, fellowships or grants: I had institutional grants from Astra Zeneca and MSD for clinical trials
   • Other interests: NONE
5. The source of funding for my participation in the work of TEAP is the United Nations Environment Programme Ozone Secretariat for expenses related to travel meetings.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Arzu Yorgancıoğlu 
Date: 2023-12-27

I, Lifei Zhang, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am the Professor and Director of Research Office of Convention Implementation Monitoring, National Research Center for Environmental Analysis and Measurement, Environmental Development Center of the Ministry of Ecology and Environment of China. My current research focuses on environmental monitoring and standardization, including monitoring related to ODS and HFCs, Hg, and POPs etc. international conventions; investigation monitoring for major regions and basins in China; developing national environmental monitoring standards, environmental planning and assessment, and chemical decomposition technologies on organic compounds and its mechanisms.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: None.  
   • Government advice and other policy development: None.
   • Paid research activities, fellowships or grants: None.  
   • Other interests: None.
5. The source of funding for my participation in the work of TEAP is UNEP.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2024 after I have signed it.

Signed: Lifei Zhang
Date: 2024-01-02